Share Name Share Symbol Market Type Share ISIN Share Description
Accsys Technologies LSE:AXS London Ordinary Share GB00BQQFX454 ORD EUR0.05
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.125p -0.17% 71.50p 71.00p 72.00p 71.75p 71.75p 71.75p 14,869 16:35:29
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Construction & Materials 41.8 -0.4 -0.8 - 64.80

Accsys Technologies (AXS) Latest News

More Accsys Technologies News
Accsys Technologies Takeover Rumours

Accsys Technologies (AXS) Share Charts

1 Year Accsys Technologies Chart

1 Year Accsys Technologies Chart

1 Month Accsys Technologies Chart

1 Month Accsys Technologies Chart

Intraday Accsys Technologies Chart

Intraday Accsys Technologies Chart

Accsys Technologies (AXS) Discussions and Chat

Accsys Technologies Forums and Chat

Date Time Title Posts
08/9/201617:29Accsys (Placing 26/10/05)1,487
30/7/201312:25Accsys recovery Ђ100m profit potential (daily mail)123
05/6/200708:52Accsys with Charts & News2
14/5/200722:55Accsys - 390% in 20 Months-
02/2/200709:21AXS Test3

Add a New Thread

Accsys Technologies (AXS) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Accsys Technologies trades in real-time

Accsys Technologies (AXS) Top Chat Posts

Accsys Technologies Daily Update: Accsys Technologies is listed in the Construction & Materials sector of the London Stock Exchange with ticker AXS. The last closing price for Accsys Technologies was 71.63p.
Accsys Technologies has a 4 week average price of 71.83p and a 12 week average price of 70.66p.
The 1 year high share price is 75.75p while the 1 year low share price is currently 56p.
There are currently 90,627,283 shares in issue and the average daily traded volume is 18,305 shares. The market capitalisation of Accsys Technologies is £64,798,507.35.
07:24 Either way, the share price has drifted down by more than a third since the July 3 results. Down 14% in July, down 9.6% in August, down 14.5% in September.
caradog: I make that cash payment of 2.2 million the equivalent of 2.5 pence per share. Dreadful decision to terminate the contract, but the 7p drop in share price seems exaggerated.
brightontrader: I know from a technology company these results are fine, talking about burn rates, reduced losses, future deals that look promising etc, and all these things are very much like a software company creating sizzle to keep the share price up or the investment to keep rolling in. However, pouring a little cold water on the results, I created and run 2 successful (small) businesses, one a software company from 89-96 which floated on Nasdaq and latterly CustomWest Shutters which I have just sold to Hillarys, and both these companies produced real profits, had to, as to make real money eventually you need real profits and you cannot exit on dreams alone, people wake up from dreams... I am investing in this until next results then if I cannot see net profits I am out, and I wonder how many others will think this way.
hjfe: hxxp:// Accsys Technologies (LON:AXS) We've only looked at this share once here, briefly on 12 Feb 2014 on a positive trading statement. My view then was that it looked expensive, but potentially interesting, due to high growth kicking in. There's another trading update today, covering the year ended 31 Mar 2014, and it sounds interesting. Total revenue has risen 78% to E33.5m, which seems to be organic growth - not often you see that type of growth rate. It appears to still be loss-making, although at a reduced extent; The overall loss for the year has reduced as expected, due to the higher revenue and resultant improvement in profitability. However, other operating costs have also increased, in part due to legal costs associated with the on-going Diamond Wood arbitration. What interests me here is that this could be an example of a company in the early stages of growth, into potentially huge markets. It makes a new type of engineered wood called Accoya, with technical advantages over conventional wood, e.g. resistance to UV light, durability, consistency of quality, etc. I'm not qualified to judge any of that, so to verify that a product does what it's meant to do, I tend to just look for rapidly increasing sales, and partnerships with big, quality companies, both of which are in evidence here. An additional factory is to be built by Solvay (a large Belgian chemicals company), to manufacture Accoya under licence, which should reduce the capex requirement, and accelerate growth. The outlook comments are light on specifics, but indicate that the company is close to profitability; The year has seen a step change in the scale of our business. The extensive efforts we have put into marketing and promoting our world leading products is now being borne out by our sales volume growth as our products gain wider market acceptance. While the global market opportunity for our products remains vast, I am conscious that Accsys remains at an early stage of its long-term journey, with much still to be achieved. However, the progress we have made during the past financial year, in sales, licensing and the significant increase in our production levels, provides me with increased confidence that we are on the right path and will achieve our objective of profitability in the near-term All of which sounds interesting. The cash position seems OK, with net cash of E15.2m at 31 Mar 2014 actually having risen since 31 Dec 2013, due to de-stocking and licence revenues received. That bank balance looks enough to hopefully mean that a dilutive fundraising is not required. With 439.2m shares in issue, and a share price of E0.225 it's not cheap, at a market cap of E98.8m, which translates into a sterling market cap of £81m. I think my previous report was wrong, as I missed the fact that the share price is quoted in Euros, and hence mistakenly thought the mkt cap was £100m, so my apologies for that schoolboy error. The shares have a dual listing on AIM, and NYSE Euronext Amsterdam. It's certainly got a speculative element, but have to say I rather like it, so have picked up a little stock today for the growth part of my portfolio. It's difficult to value, but I like the move towards profit, the rapid % growth, cash in the bank, and the large potential market size. Perhaps any readers who have dug deeper into this share could add some comments below? - See more at: hxxp://
brightontrader: asmodeus, no idea on medite sales sorry, bob5, don't beleive everything you read, if the majority of replacement timber sash was using Accoya the share price would be £1+.....
spudders: bt- Yep still here with my heavy loss. Still hold though. Lost interest in AXS just check in every now and then. I believe you have a lake which you have stocked with trout, if its a day ticket maybe next season I could have a go at hooking a couple of rainbows, much more fun than watching the AXS share price. I hope you make a decent living from your exports. All the best, spudders
tsk 1: The share price (following a 30% drop or thereabouts since the announcement) seems to have settled. As for the comparative price of Accoya, to quote from the 2010 interims: "Revenue from sales of Accoya® wood produced by our Arnhem plant increased by 81% to €6.5m in the first half of the year compared to the same six months in the previous year." That's about £5.5m worth of sales, so I guess some people think the price of Accoya is not too bad.
damanko: Interesting and sizeable write-up in yesterday's Sunday Times, in the "Green" section of the Business. Won't attempt a link, as I believe this stuff is paid for these days. Clegg The Elder came across as well regarded, and gave the impression he was on top of things, a few (normal) remarks about conkers, vinegar etc. Curiously there was no mention that the company is in trouble or cash strapped, nor the share price behaviour over the past couple of years. The whole thing was geared toward the future of the product, the manufacturing plant in Holland, and the growing number of license agreements, worldwide.
ebomber: TELEGRAPH ARTICLE IN FEB 2010 Nick Clegg faces a challenge persuading the electorate to believe in the Liberal Democrats as a party of government. But his elder brother Paul faces a similarly daunting challenge. He needs to rebuild the belief of investors who have lost large sums in Accsys Technologies while he steers the company to profitability. Warning signs on nuclear powerConkers provide a clue to Accsys' original appeal to investors. When soaked in vinegar and oven baked, conkers become extra hard. Accsys uses a similar patented process called acetylation to change softwoods at a molecular level, making them more stable, durable and strong than teak and other precious hardwoods. Investors were excited by the prospect of turning abundant, fast-growing softwood from certified sustainable forests into a high performance material called Accoya with a 50-year guarantee. With reputable customers specifying timber from sustainable sources and legislators clamping down on chemical treatments, Accoya offered an attractive solution. Having originally been created through Dutch government funding of a university research project, Accsys raised €27m (£24m) through a listing on Aim in October 2005. This funded an acetylation plant in Arnhem. The company was listed on Euronext in September 2007 and corporate investors rushed in. The share price grew to €4.58, giving a market capitalisation of more than €600m. "Everyone in Accsys felt like they could walk on water," says Clegg, "and shared the investors' vision of royalties flooding in from licensees". It got off to a good start. A Saudi group bought licences for the Gulf states and an American entrepreneur called Greg Lee formed a new company called Diamond Wood to produce Accoya in China. "People assumed Accoya would sell itself," says Clegg. This led to "some bad management decisions" including a structure with an executive chairman in Geneva and a chief executive who managed the Arnhem plant and the Hammersmith central offices from premises in Dallas. As the global economy deteriorated, sales of licences dried up completely. Potential licensees were unable to raise the necessary funds to invest in production plants that would typically take two years to come on stream. The problem was compounded by a drop in hardwood prices. Accsys was slow to react. "The company over-committed on expenditure before achieving the sales it needed," says Clegg, especially when the business was losing an average of €2.7m a month. The share price sank to €0.51 as investors realised the firm would run out of money if the cash-burn continued. Clegg joined the board in April 2009, after years running European operations for an American investment bank, with a mission to restructure the business and cut costs. Urgent action was essential. In one dramatic month the workforce was cut from 150 to 102, the travel bill was slashed by €100,000 per month and costs reduced by 25pc. Instead of waiting for big licence deals to arrive, Accsys focused its sales effort onto distribution agreements for the Accoya wood produced in Arnhem. A dozen distributors in countries as diverse as China and Scandinavia now sell Accoya. Some successes have been achieved, including its use for a 32 metre road bridge and canal lining in Holland, and all the walkways and kiosks at Disneyland in Hong Kong. But there is no "landmark" project yet, with most of the uses for Accoya being "bread and butter" applications such as door and window frames. Clegg has also succeeded in raising a further €17m from institutional investors but unless Accsys can start generating income quickly, its share value will drop further and the company risks being snapped up by a private equity company. Much will depend upon the success of Greg Lee in raising €80m for his production plant in Nanjing. If he is successful, Accsys receives a lump sum payment of €4m and €750k per month until the royalties kick in. This will give a positive cash flow. Accsys is also working on a joint development project with Medite, one of Europe's biggest producers of MDF (medium-density fibreboard). Acetylated wood fibres and chips can be used in long-lasting wood panel products that can be used outdoors. Some observers believe the potential for the Tricoya panels will be even greater than that for Accoya wood. The number of live discussions with potential licensees has grown three-fold since September, but despite "life coming back to the market", no extra licence sales have been achieved yet. "We have taken Accsys from a wood acetylation R&D company with the world's largest wood modification plant," says Clegg, "into a commercially focused company selling licences in wood acetylation." 2010 is going to be a crucial year. "It is all about sales and business development now," says Clegg. "If we get it right our market capitalisation will be between €1bn to €2bn within five to six years." If they get it wrong, there will be a lot of very disappointed investors.
damanko: Fryern, not a moan, it was a comment. I doubt whether anyone else on this thread is remotely interested in Medicsight. Just start another thread. Full stop. Please try not to tell all again about Cairn, you've put that in writing several times already. It's probably an age thing. Whatever the outcome of the Celanese holding & option, it bodes well for AXS share price in the medium term. Also started to be tipped elsewhere as a growth stock, though it took 18 months and a near trebling of the share price for these experts to "discover" it. Ho hum...
Accsys Technologies share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V: D:20161023 18:00:29